Hyperglycemia Clinical Trial
Official title:
GLP-1 Suppression of Alpha Cell Secretion in T2DM
The incretin hormone glucagon-like peptide-1 (GLP-1) has known insulinotrophic and
glucagonostatic properties. However, inpatients with type 2 diabetes mellitus (T2DM)it is
shown, that the beta cell sensitivity towards GLP-1 is decreased, when comparing to healthy
controls. Further, these patients have decreased GLP-1 response to a meal.
The aim of this study is to elucidate if the diabetic hyperglucagonemia, seen in these
patients both during fasting and in a postprandial condition, is coursed by a decreased
sensitivity to GLP-1 in the diabetic alpha cell.
Ten T2DM patients and ten matched healthy control subjects will be examined on two separate
days. Day 1: increasing GLP-1 infusions and Day 2: saline. During both days plasma glucose
(PG) will be clamped at fasting level (FPG).
Patients with T2DM will be submitted til a Day 3, here PG will be normalized over-night by
an adjustable insulin infusion, on the following day the GLP-1 infusion of Day 1 will be
repeated.
The hypothesis is that these patients have decreased alpha cell sensitivity to GLP-1 as is
the case with the beta cell sensitivity. This decreased sensitivity, the investigators
speculate, contributes the defect suppression og glucagon and thereby to the increased PG
levels seen in T2DM. Further the investigators will elucidate if this sensitivity can be
increased by normalizing the diabetic PG to a normal FPG level.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01267448 -
Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia
|
Phase 4 | |
| Recruiting |
NCT03775733 -
Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Hyperglycemia
|
N/A | |
| Completed |
NCT03482154 -
Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
|
||
| Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
| Completed |
NCT03675360 -
Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial
|
N/A | |
| Completed |
NCT00535600 -
Effects of Bariatric Surgery on Insulin
|
||
| Not yet recruiting |
NCT06159543 -
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
|
N/A | |
| Recruiting |
NCT02885922 -
The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients
|
||
| Recruiting |
NCT02885909 -
Inpatient Blood Glucose Control in Taichung Veterans General Hospital
|
Phase 4 | |
| Completed |
NCT02012465 -
Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients
|
Early Phase 1 | |
| Withdrawn |
NCT01488383 -
Effect of Stevioside in Postpandrial Glucose in Healthy Adults
|
N/A | |
| Completed |
NCT01805414 -
Breakfast Nutrition and Inpatient Glycemia
|
N/A | |
| Completed |
NCT01803568 -
Skeletal Muscles, Myokines and Glucose Metabolism MYOGLU
|
N/A | |
| Completed |
NCT01810952 -
The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients
|
Phase 4 | |
| Active, not recruiting |
NCT01247714 -
Clinical Evaluation of a Specific Enteral Diet for Diabetics
|
N/A | |
| Not yet recruiting |
NCT00846144 -
The Reduction in Glucose Stimulated Insulin Secretion Induced by Cytokines May be Prevented by Copper Addition - Studies in Diabetic Patients
|
N/A | |
| Completed |
NCT00996099 -
Continuous Glucose Monitoring Combined With Computer Algorithm for Intensive Insulin Therapy in Cardiosurgical Patients
|
N/A | |
| Recruiting |
NCT00654797 -
Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2
|
Phase 2 | |
| Completed |
NCT00468494 -
Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia?
|
N/A | |
| Completed |
NCT00394407 -
Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes
|
Phase 4 |